Provided is a centrifugal separation container for separating a material from tissue and body fluids by using a centrifugal force, including: a first container; a second container; a first piston positioned in the inside of the first container and configured to be movable up and down in the inside of the first container; an elastic body positioned below the first piston in the inside of the first container and configured to elastically bias the first piston upward; a first connecting duct having one end connected to the first container and the other end connected to the second container; and a first control valve operating by a centrifugal force and configured to open and close the first connecting duct.

A centrifugal separator includes a rotating body driving and sealing structure in which a hermetically sealed space is formed between a rotating body and an outer case by sealing the inside and outside using a noncontact seal during rotation of the rotating body, in an airtight manner. A rotation coupling unit is provided at the upper end of a centrifugal cylinder, and even when the centrifugal cylinder is deformed during use causing an internal fluid to leak through a fitting portion of a bottom member to the centrifugal cylinder, the fluid leaks in the hermetically sealed space so that the driving system or the like is not contaminated.

A process for the sequential processing of opaque and transparent biological fluids such as whole blood, apheresis blood, bone marrow blood, umbilical cord blood, buffy coat or cultured cells by processing steps in a hollow cylindrical centrifugal processing chamber (300) which is part of a disposable set. At least three different procedures selected from washing, incubation, transduction, separation, density gradient separation, dilution and volume adjustment are each carried out once or repeated a number of times according to a given processing profile in the processing chamber. Each procedure involves an input into the processing chamber, an operation in the processing chamber and an output from the processing chamber by displacement of a piston (310). The at least three different procedures are sequentially chained one after the other to constitute an overall sequential operation in the processing chamber and its disposable set. A first application is incubation for binding magnetic beads with human blood cells or stem cells. A second application is transduction by which foreign genetic material is inserted into human blood cells or stem cells by a virus. A third application is reconditioning biological fluids to achieve reproducible concentration and volumes of blood cells or stem cells.

Centrifuges are useful to, among other things, remove red blood cells from whole blood and retain platelets and other factors in a reduced volume of plasma. Platelet rich plasma (PRP) and or platelet poor plasma (PPP) can be obtained rapidly and is ready for immediate injection into the host. Embodiments may include valves, operated manually or automatically, to open ports that discharge the excess red blood cells and the excess plasma into separate receivers while retaining the platelets and other factors in the centrifuge chamber. High speeds used allow simple and small embodiments to be used at the patient's side during surgical procedures. The embodiments can also be used for the separation of liquids or slurries in other fields such as, for example, the separation of pigments or lubricants.

Disclosed is a bioprocessing system comprising apparatus (200) including a centrifugal separation housing (210) having a temperature controllable compartment (215) for removably accepting a separation chamber (50), the apparatus further comprising at least one mixing station (250) for supporting one or more fluid storage vessels (10, 20, 30, 40), the station including a temperature controllable area (252) for increasing or decreasing the temperature of the contents of the or each supported vessel. The system further includes a disposable fluidic arrangement (100) including a centrifugal separation chamber (50) removably mountable within the compartment (215) and having one or more ports (52) allowing fluid ingress into, or egress out of the chamber, via the one or more ports in use, said ports being in fluid communication with one or more of said fluid storage vessels via fluid conduits (12, 22, 32, 42) and via one or more valve arrangement.

Provided is a centrifugal member that centrifuges a cell suspension, the centrifugal member including: a cylindrical main body extending in a cylindrical shape in a centrifugal direction, having an inner end wall formed at an inner end in the centrifugal direction, and having an outer end in the centrifugal direction opened; a gasket slidably inserted into an inner portion of the cylindrical main body in the centrifugal direction; a pusher connected to an outer side of the gasket in the centrifugal direction; and a port provided on the inner end wall and communicating with the inner portion of the cylindrical main body.

Centrifuges are useful to, among other things, remove red blood cells from whole blood and retain platelets and other factors in a reduced volume of plasma. Platelet rich plasma (PRP) and or platelet poor plasma (PPP) can be obtained rapidly and is ready for immediate injection into the host. Embodiments may include valves, operated manually or automatically, to open ports that discharge the excess red blood cells and the excess plasma into separate receivers while retaining the platelets and other factors in the centrifuge chamber. High speeds used allow simple and small embodiments to be used at the patient's side during surgical procedures. The embodiments can also be used for the separation of liquids or slurries in other fields such as, for example, the separation of pigments or lubricants.

Plasma/cell concentrator apparatus and methods are described herein for concentrating constituents from a fluid. Generally, a volume of the fluid may be urged from a first reservoir to a second reservoir through a fluid channel and a volume of desiccant for mixing with the fluid may be introduced to create a mixture. This fluid and desiccant mixture may be passed between the first and second reservoirs until one or more components from the fluid are absorbed by the desiccant. After mixing, the fluid may be withdrawn through a withdrawal channel which is in fluid communication with the fluid channel while preventing the desiccant from passing into the withdrawal channel.

A dual piston centrifuge tube includes an elongate tubular receptacle having upper and lower ends interconnected by a sidewall. First and second common inlet/outlet ports are formed respectively in the upper and lower ends of the tubular receptacle. First and second liquid impermeable pistons are mounted within an interior chamber of the tubular receptacle for sliding longitudinally therein. The first piston is interconnected to the first port by a flexible fluid-conducting pipe that extends through the first piston to communicate with a region of the chamber between the first and second pistons. Blood or other biological fluid is introduced through the first port and pipe into the tubular receptacle to drive the first piston upwardly. The tube is centrifuged to separate the fluid into a plurality of constituent component levels between the first and second pistons. One of the layers is aspirated through the pipe and first port and re-introduced into the receptacle through the second port. The tube is centrifuged a second time to separate the re-introduced fluid into constituent components, which are then aspirated through the second port.

A blood product (10), a method for preparing the blood product, a blood product obtainable by the method and a blood product preparing container means. The blood product comprises components from whole blood, especially fibrin, thrombocytes and leukocytes. The blood product (10) comprises a first layer (21), a second layer (22) and a third layer (23). The second layer (22) is adjacent to the first layer (21) and the third layer (23). The first layer (21) defines a first outer surface (24) of the blood product (10) and the third layer (23) defining a second outer surface (25) of the blood product (10). The first layer (21) comprises a majority of fibrin, the second layer (22) comprises a majority of thrombocytes and the third layer (23) comprises a majority of leukocytes.